Results
|
|
16141.
|
|
|
|
16142.
|
|
|
|
16143.
|
|
|
|
16144.
|
|
|
|
16145.
|
|
|
|
16146.
|
|
|
|
16147.
|
Cardiovascular risk factors in acromegaly before and after normalization of serum IGF-I levels with the GH antagonist pegvisomant. [electronic resource] by
- Sesmilo, Gemma
- Fairfield, Wesley P
- Katznelson, Laurence
- Pulaski, Karen
- Freda, Pamela U
- Bonert, Vivien
- Dimaraki, Eleni
- Stavrou, Stavros
- Vance, Mary Lee
- Hayden, Douglas
- Klibanski, Anne
Producer: 20020425
In:
The Journal of clinical endocrinology and metabolism vol. 87
Availability: No items available.
|
|
|
16148.
|
|
|
|
16149.
|
|
|
|
16150.
|
|
|
|
16151.
|
|
|
|
16152.
|
|
|
|
16153.
|
|
|
|
16154.
|
|
|
|
16155.
|
|
|
|
16156.
|
|
|
|
16157.
|
|
|
|
16158.
|
|
|
|
16159.
|
|
|
|
16160.
|
|